Common use
Clomiphene is a well-established non-steroidal fertility medication specifically designed to induce ovulation in women who experience anovulation (absence of ovulation) or irregular ovulatory cycles. As a widely trusted Clomid generic, clomiphene is one of the first-line treatments prescribed for female fertility issues and is commonly used for women diagnosed with polycystic ovary syndrome (PCOS), a hormonal condition that frequently disrupts normal ovulation patterns. This ovulation stimulation medication works by blocking estrogen receptors in the hypothalamus, which tricks the body into perceiving low estrogen levels and triggers the release of gonadotropin-releasing hormone (GnRH). This cascade stimulates the pituitary gland to produce increased levels of follicle-stimulating hormone (FSH) and luteinizing hormone (LH) — the essential hormones needed to trigger ovulation induction and mature egg development. Clomiphene is also used in cases of unexplained infertility where standard diagnostic evaluations have not identified a clear cause. Additionally, it may be prescribed off-label to boost testosterone levels in men with secondary hypogonadism, making it a versatile fertility medication with applications beyond female reproductive health.

Dosage and direction
Clomiphene is taken orally as a tablet, usually once daily for five consecutive days early in the menstrual cycle. Treatment typically begins on cycle day 3, 4, or 5, as directed by your fertility specialist. The standard initial dose for ovulation induction is 50 mg per day, which represents the lowest effective dose for most women. If ovulation does not occur during the first cycle, the dose may be increased to 100 mg per day in subsequent cycles, with a maximum recommended dose of 150 mg per day in carefully monitored patients. Treatment with this Clomid generic should be supervised by a qualified physician who can monitor follicular development through ultrasound and hormone blood tests. Therapy should generally not exceed six ovulatory cycles in total, as the likelihood of achieving pregnancy diminishes with each additional unsuccessful cycle, and alternative fertility treatments may need to be considered. Timing of intercourse or intrauterine insemination (IUI) is typically coordinated with the predicted ovulatory window, which usually occurs 5 to 10 days after the last clomiphene tablet is taken. Your doctor may also recommend ovulation predictor kits or mid-cycle ultrasound monitoring to pinpoint the optimal timing for conception.

Precautions
Before beginning clomiphene therapy for infertility treatment, patients should undergo a thorough medical evaluation to identify all potential causes of infertility, including a complete pelvic examination, assessment of partner fertility, hormone level testing, and evaluation of fallopian tube patency. Caution is advised in patients with liver dysfunction, as clomiphene is metabolized by the liver, and impaired hepatic function may lead to elevated drug levels. Women with existing ovarian cysts unrelated to polycystic ovaries should not start treatment until the cysts have resolved, as ovulation stimulation could cause further enlargement and potential rupture. Patients with unexplained abnormal uterine bleeding should be fully evaluated before starting therapy. Clomiphene may cause visual disturbances including blurred vision, light sensitivity, floaters, or flashes — if any visual symptoms occur, treatment should be discontinued and an ophthalmologic evaluation performed. Care should be taken when driving or operating machinery during treatment. One of the most important considerations with this fertility medication is the increased risk of multiple pregnancies (twins or higher-order multiples) due to the stimulation of more than one ovarian follicle during a single cycle.

Contraindications
Clomiphene is contraindicated in individuals with active liver disease or a history of liver dysfunction, as the drug undergoes hepatic metabolism and may worsen hepatic conditions. It should not be used in patients with uncontrolled thyroid disorders or adrenal gland dysfunction, as these endocrine imbalances must be corrected before fertility treatment can be safely initiated. Ovarian enlargement of unknown cause (other than documented PCOS) is a contraindication, as ovulation stimulation may lead to dangerous ovarian hyperstimulation. Clomiphene must not be used during pregnancy, as it offers no therapeutic benefit once conception has occurred and may pose risks to fetal development. Patients with known or suspected hormone-dependent tumors, including certain types of breast or uterine cancer, should avoid clomiphene entirely. The medication is also contraindicated in individuals with a known hypersensitivity to clomiphene citrate or any of its inactive components. Women with an existing ovarian cyst not related to PCOS should not begin therapy due to the elevated risk of ovarian rupture and potentially life-threatening complications.

Possible side effect
Common side effects of clomiphene include hot flashes or flushing (experienced by up to 10% of patients), abdominal discomfort or bloating, pelvic pressure, breast tenderness or swelling, and mild nausea. Some women may experience headache, mood swings, irritability, or emotional sensitivity during treatment — these hormonal fluctuations are generally temporary and resolve after the medication cycle is complete. Weight gain and mild skin breakouts have also been reported. Rare but medically significant side effects include visual disturbances such as blurred vision, double vision, or persistent afterimages, which require immediate discontinuation of therapy. Ovarian hyperstimulation syndrome (OHSS) is an uncommon but potentially serious complication characterized by significant ovarian enlargement, abdominal swelling, nausea, vomiting, and in severe cases, fluid accumulation in the abdomen or chest. Immediate medical attention should be sought if severe pelvic pain, rapid weight gain, difficulty breathing, or significant visual symptoms occur during treatment with this fertility medication.

Drug interaction
There are relatively few known serious drug interactions with clomiphene, but certain precautions should be observed. Clomiphene may alter the effects of other hormone-based therapies, including oral contraceptives and estrogen supplements, potentially reducing their efficacy or creating unpredictable hormonal fluctuations. Concurrent use with other fertility drugs or ovulation stimulation agents, such as gonadotropins, should only be undertaken under direct medical supervision with appropriate monitoring to prevent ovarian hyperstimulation. Patients should inform their healthcare provider of all medications and dietary supplements they are taking, particularly those that influence hormonal balance, thyroid function, or liver metabolism. Alcohol consumption may intensify common side effects like dizziness, headache, and mood changes, so moderation is recommended during treatment. Certain herbal supplements, including those marketed for female fertility support, may interact with clomiphene's mechanism of action, and their use should be discussed with your prescribing physician.

Missed dose
If a dose of clomiphene is missed, it should be taken as soon as you remember, provided it is not too close to the time of the next scheduled dose. Do not take a double dose to compensate for the missed one, as this could increase the risk of ovarian hyperstimulation and other side effects. Because clomiphene is taken during a critical five-day window in the menstrual cycle, missing a dose during the ovulation induction phase may reduce the chance of successful conception in that particular cycle. If more than one dose is missed or if you are unsure how to proceed, consult your fertility specialist or physician promptly for guidance — they may advise continuing the current cycle or waiting for the next menstrual period to restart treatment.

Overdose
Symptoms of a clomiphene overdose may include nausea, vomiting, hot flashes, visual disturbances such as blurred vision or light sensitivity, and significant abdominal pain or bloating. Severe cases may involve dangerous ovarian enlargement, ovarian hyperstimulation syndrome (OHSS), or fluid shifts that require hospitalization. Medical attention is necessary immediately if overdose is suspected. There is no specific antidote for clomiphene overdose, and treatment is supportive — focused on managing symptoms, monitoring ovarian size via ultrasound, and maintaining fluid and electrolyte balance until the drug is cleared from the system.

Storage
Store clomiphene tablets at controlled room temperature between 15°C and 30°C (59°F to 86°F), away from direct light, excessive heat, and moisture. Keep the medication in its original packaging with the container tightly closed, and always store it out of reach of children. Do not use clomiphene after the expiration date printed on the label, as expired fertility medication may have diminished potency. Follow local pharmaceutical disposal guidelines for any unused or expired medication — never share prescription fertility drugs with others.

Disclaimer
We provide only general information about medications which does not cover all directions, possible drug integrations, or precautions. Information at the site cannot be used for self-treatment and self-diagnosis. Any specific instructions for a particular patient should be agreed with your health care adviser or doctor in charge of the case. We disclaim reliability of this information and mistakes it could contain. We are not responsible for any direct, indirect, special or other indirect damage as a result of any use of the information on this site and also for consequences of self-treatment.